Fig. 4: Pathways consistently altered between responders and non-responders.
From: Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analyses
A q-value by Max-P and Vote Sums for pathways identified as enriched across the nine comparisons of responders vs. non-responders (q < 0.05 by Max-P). * indicates pathways also enriched by Freq50 (p < 0.05 in greater than half of comparisons). B Network diagram showing similarity between pathways, with labels provided in A. Pathways sharing more genes are plotted closer together. C Number of pathways identified as significantly enriched in responders or non-responders (q < 0.05) by Fisher’s meta-analysis, DS3 (Human LCL’s), and the naturalistic study by Jansen et al.
